PubMed

The effect of thyroid hormone on skeletal integrity.

Greenspan SL, Greenspan FS.

Ann Intern Med. 1999 May 4;130(9):750-8. Review.PMID: 10357695 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis.

Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY.

J Clin Endocrinol Metab. 1996 Dec;81(12):4278-89.PMID: 8954028 [PubMed - indexed for MEDLINE]Related articles

The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature.

Schneider R, Reiners C.

Exp Clin Endocrinol Diabetes. 2003 Dec;111(8):455-70. Review.PMID: 14714266 [PubMed - indexed for MEDLINE]Related articles

Risk for fracture in women with low serum levels of thyroid-stimulating hormone.

Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group.

Ann Intern Med. 2001 Apr 3;134(7):561-8.PMID: 12803168 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.

Chen CH, Chen JF, Yang BY, Liu RT, Tung SC, Chien WY, Lu YC, Kuo MC, Hsieh CJ, Wang PW.

J Formos Med Assoc. 2004 Jun;103(6):442-7.PMID: 15278189 [PubMed - indexed for MEDLINE]Related articles

Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.

Appetecchia M.

Horm Res. 2005;64(6):293-8. Epub 2005 Nov 1.PMID: 16269872 [PubMed - indexed for MEDLINE]Related articles

Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.

Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmartí A.

Endocr Relat Cancer. 2005 Dec;12(4):973-81.PMID: 16322336 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.

Heemstra KA, Hamdy NA, Romijn JA, Smit JW.

Thyroid. 2006 Jun;16(6):583-91.PMID: 16839260 [PubMed - indexed for MEDLINE]Related articles

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ.

JAMA. 2004 Jan 14;291(2):228-38. Review.PMID: 14722150 [PubMed - indexed for MEDLINE]Related articlesFree article

The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women.

Morris MS.

Bone. 2007 Apr;40(4):1128-34. Epub 2007 Jan 22.PMID: 17236836 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

Impact on bone of thyroid hormone therapy.

Lauwers A, Alexandre C.

Rev Rhum Engl Ed. 1997 Feb;64(2):112-9. Review.PMID: 9085446 [PubMed - indexed for MEDLINE]Related articles

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR.

Arch Intern Med. 2000 Jul 24;160(14):2161-6.PMID: 10904459 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.

Jódar E, Martínez-Díaz-Guerra G, Azriel S, Hawkins F.

Calcif Tissue Int. 2001 Aug;69(2):84-7.PMID: 11683428 [PubMed - indexed for MEDLINE]Related articles

[Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women]

Ortiz Núñez DA, Mengchún López G, Hernández Marín I, Mendoza R, Ayala Ruíz AR.

Ginecol Obstet Mex. 2004 Jul;72:349-55. Spanish. PMID: 15469174 [PubMed - indexed for MEDLINE]Related articles

Bone loss in thyroid disease: role of low TSH and high thyroid hormone.

Abe E, Sun L, Mechanick J, Iqbal J, Yamoah K, Baliram R, Arabi A, Moonga BS, Davies TF, Zaidi M.

Ann N Y Acad Sci. 2007 Nov;1116:383-91. Review.PMID: 18083940 [PubMed - indexed for MEDLINE]Related articles

Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women.

Belaya ZE, Melnichenko GA, Rozhinskaya LY, Fadeev VV, Alekseeva TM, Dorofeeva OK, Sasonova NI, Kolesnikova GS.

Hormones (Athens). 2007 Jan-Mar;6(1):62-70.PMID: 17324919 [PubMed - indexed for MEDLINE]Related articlesFree article

Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism.

Bassett JH, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG, Weiss RE, Roux JP, Malaval L, Clement-Lacroix P, Samarut J, Chassande O, Williams GR.

Mol Endocrinol. 2007 May;21(5):1095-107. Epub 2007 Feb 27.PMID: 17327419 [PubMed - indexed for MEDLINE]Related articlesFree article

Thyroid hormone excess and osteoporosis.

Leb G, Warnkross H, Obermayer-Pietsch B.

Acta Med Austriaca. 1994;21(2):65-7. Review.PMID: 7527991 [PubMed - indexed for MEDLINE]Related articles

Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism.

Mudde AH, Houben AJ, Nieuwenhuijzen Kruseman AC.

Clin Endocrinol (Oxf). 1994 Oct;41(4):421-4.PMID: 7955452 [PubMed - indexed for MEDLINE]Related articles